Tactile Medical (TCMD)
Builds prescribed home-therapy devices for lymphedema and airway clearance.
$22.41
At close+0.16 (+0.72%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions186 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | ≈ 96.98% | 21.97M shares | |
| Insiders13 holders · as of Aug 12, 2026 | 8.94% | 2.02M shares | |
| Strategic holders1 holder · as of Feb 11, 2021 | 0.12% | 27.4K shares | |
| Adds to | 106.04% |
22.65M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 106.04%; nothing is left for Other.
Institutions13F, as of Jun 30, 2026
186 holders · 21.97M shares · 30 new positions · 112 increased · 43 reduced · 33 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 1.91M | 8.41% | +125.6K | Aug 7, 2026 |
| Cadian Capital Management, LP | 1.58M | 6.96% | +535.9K | Aug 14, 2026 |
| Dimensional Fund Advisors LP | 1.09M | 4.82% | +12.5K | Aug 11, 2026 |
| Morgan Stanley | 979.3K | 4.32% | −403.5K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 970.2K | 4.28% | +25.1K | Aug 13, 2026 |
| Driehaus Capital Management LLC | 937.8K | 4.14% | +195.9K | Aug 14, 2026 |
| Acadian Asset Management LLC | 903.6K | 3.99% | −1.8K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 706.5K | 3.12% | +38.2K | Aug 13, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.70% | 1.82M | 13G | Apr 24, 2025 ↗ |
| Paradigm Capital Management, Inc. | 6.94% | 1.66M | 13G | Nov 13, 2024 ↗ |
| Morgan Stanley | 5.80% | 1.29M | 13G | Feb 12, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 10, 2026 | Sheri Louise Dodddirector, officer: Chief Executive Officer | Sale | 10,978 | $29.44 | 232,907 |
| May 11, 2026 | Elaine M. Birkemeyerofficer: CHIEF FINANCIAL OFFICER | Sale | 4,631 | $24.49 | 130,188 |
| Feb 24, 2026 | Kristie Burnsofficer: Sr. VP Mktg & Clinical Affairs | Sale | 6,246 | $28.94 | 82,581 |
| Feb 24, 2026 | Elaine M. Birkemeyerofficer: CHIEF FINANCIAL OFFICER | Sale | 7,701 | $28.94 | 134,819 |
| Feb 24, 2026 | Sheri Louise Dodddirector, officer: Chief Executive Officer | Sale | 10,993 | $28.94 | 243,885 |
| Feb 23, 2026 | Kristie Burnsofficer: Sr. VP Mktg & Clinical Affairs | Sale · 2 lots | 4,439 | $28.30 | 88,827 |
| Feb 23, 2026 | Sheri Louise Dodddirector, officer: Chief Executive Officer | Sale · 2 lots | 15,240 | $28.30 | 254,878 |
| Feb 23, 2026 | Elaine M. Birkemeyerofficer: CHIEF FINANCIAL OFFICER | Sale · 2 lots | 5,518 | $28.30 | 142,520 |
| Jan 2, 2026 | Kristie Burnsofficer: Sr. VP Mktg & Clinical Affairs | Sale | 5,139 | $28.85 | 72,401 |
CongressHouse and Senate disclosures
Not reported.